Top news
Hydroxychloroquine: India agrees to release drug after Trump retaliation threat
'What do you have to lose?': Inside Trump's embrace of a risky drug against coronavirus
By Laurie McGinley, Josh Dawsey & Philip Rucker
CDC removes guidance on drugs touted by Trump to treat coronavirus
By Madeline Holcombe, Jen Christensen & Joe Sutton
All coverage
After Trump's statements about hydroxychloroquine, lupus and arthritis patients face drug shortage
By Elizabeth Cohen & Marshall Cohen
Fox News Figures Met With Trump to Discuss Hydroxychloroquine: Report
By Daniel Villarreal
How Trump Became Obsessed with Hydroxychloroquine
By Luke Darby
Fact check: Did a Democratic lawmaker in Michigan credit Trump for her COVID-19 recovery?
By Matthew Brown
India’s Drugmakers Ramp Up Production Of ‘Game-Changer’ Coronavirus Drug Hydroxychloroquine
By Anu Raghunathan
CDC removes unusual guidance to doctors about drug favored by Trump
By Marisa Taylor & Aram Roston
Analysis | Trump's promotion of hydroxychloroquine is almost certainly about politics, not profits
By Philip Bump
Coronavirus: India drops export ban on hydroxychloroquine after Trump threat
By Arshad Rasool Zargar
Trump's Aggressive Advocacy of Malaria Drug for Treating Coronavirus Divides Medical Community (Published 2020)
By Katie Rogers, Maggie Haberman & Peter Baker
Does Trump Benefit Financially by Promoting Hydroxychloroquine as COVID-19 Treatment?
By Alex Kasprak
India allows limited exports of anti-malaria drug after Trump warns of retaliation
By Sanjeev Miglani & Neha Dasgupta
Trump Has ‘Small,’ ‘Distant Link’ To Sanofi, French Drugmaker Of Hydroxychloroquine
By Lisette Voytko